Advanced Wound Care Market worth 13.07 Billion USD by 2022

The report "Advanced Wound Care Market by Product (Dressings (Foams, Hydrocolloids, Alginates), Therapy Devices, NPWT, Autograft, Allograft, Xenograft), Wound (Surgical, Trauma, Diabetic Foot, Ulcers, Burns), End User (Hospital, Home Care) - Global Forecast to 2022".

The global advanced wound care market is expected to reach USD 13.07 Billion by 2022 from USD 10.43 Billion in 2017, at a CAGR of 4.6%. Factors driving the growth of this market include the increasing prevalence of surgical wounds & ulcers (diabetic foot ulcers, pressure ulcers, and venous leg ulcers), increasing aging population, increasing demand for evidence- based advanced wound care products, rising R&D activities, advancements in the field of advanced wound care research, and increasing awareness about wound care treatment.

North America is estimated to command the largest share of the market

Based on region, the advanced wound care market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2017, North America is estimated to account for the largest share of the global wound care market. The large share of North America is attributed to the growing geriatric population, surging prevalence of chronic wounds, and product launches in this region.

The key players in the advanced wound care market are Smith & Nephew (UK), Mölnlycke Health Care (Sweden), B. Braun (Germany), ConvaTec Group (US), Coloplast (Denmark), Integra LifeSciences(US), 3M Company (US), Cardinal Health (US), Acelity L.P. (US), Medtronic (US), MPM Medical (US), PAUL HARTMANN (Germany), Medline Industries (US), Lohmann & Rauscher (Germany), Advanced Medical Solutions Group (UK), BSN medical GmbH (Germany), Wound Care Technologies (US), Vivostat A/S (Denmark), Organogenesis (US), Hematris Wound Care (Germany), Alliqua BioMedical (UK), MiMedX Group (US), Triage Meditech (India), DeRoyal Industries (US), and Laboratoires URGO (UK).